Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus

International Journal of Cardiovascular Imaging

Volumn 24, Issue 2, 2008, Pages 125-132

  Kawaguchi, Ren ^a   Sabate, Manel ^b   Angiolillo, Dominick J ^a   Jimenez Quevedo, Pilar ^b   Suzuki, Nobuaki ^a   Corros, Cecilia ^b   Futamatsu, Hideki ^a   Alfonso, Fernando ^b   Hernandez Antolin, Rosana ^b   Macaya, Carlos ^b   Bass, Theodore A ^a   Costa, Marco A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Drug eluting stent; Intimal hyperplasia; IVUS; Overlap stenting

Indexed keywords

CLOPIDOGREL; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; PACLITAXEL; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG ELUTING STENT; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STENT; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPERPLASIA; IMAGING, THREE-DIMENSIONAL; MALE; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS; STENTS; TACROLIMUS; TREATMENT OUTCOME; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 38349139303     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-007-9235-7     Document Type: Article

References (31)

1. Kip KE, Faxon DP, Detre KM et al (1996) Coronary angioplasty in diabetic patients. The national heart, lung, and blood institute percutaneous transluminal coronary angioplasty registry. Circulation 94:1818-1825
2. Angiolillo DJ, Bernardo E, Ramirez C et al (2006) Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol 48:298-304
3. Mathew V, Gersh BJ, Williams BA et al (2004) Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: A report from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 109:476-480
4. Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231
5. Colombo A, Drzewiecki J, Banning A et al (2003) Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108:788-794
6. Schampaert E, Cohen EA, Schluter M et al (2004) The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43:1110-1115
7. Schofer J, Schluter M, Gershlick AH et al (2003) Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 362:1093-1099
8. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780
9. Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323
10. Sabate M, Jimenez-Quevedo P, Angiolillo DJ et al (2005) Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 112:2175-2183
11. Ellis SG, Savage M, Fischman D et al (1992) Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 86:1836-1844
12. Finn AV, Kolodgie FD, Harnek J et al (2005) Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112:270-278
13. Corros C, Sabate M, Jimenez-Quevedo P et al (2005) Efficacy of paclitaxel-eluting stent implantation in diabetic patients with de novo coronary stenoses. Final results of the DIABETES II trial. Am J Cardiol 96:41H
14. Sabate M, Ferrer MC, Jimenez-Quevedo P et al (2006) Efficacy of tacrolimus-eluting stent to prevent restenosis in diabetic patients. Final results of the DIABETES-3 trial. Am J Cardiol 98:117M
15. Abizaid A, Albertal M, Costa MA et al (2004) First human experience with the 17-beta-estradiol-eluting stent: The estrogen and stents to eliminate restenosis (EASTER) trial. J Am Coll Cardiol 43:1118-1121
16. Futamatsu H, Sabate M, Angiolillo DJ et al (2006) Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: A three-dimensional volumetric intravascular ultrasound outcome study. J Am Coll Cardiol 48:1139-1145
17. Jimenez-Quevedo P, Sabate M, Angiolillo DJ et al (2006) Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the diabetes and sirolimus-eluting stent (DIABETES) trial. J Am Coll Cardiol 47:2172-2179
18. Kozuma K, Costa MA, Sabate M et al (1999) Late stent malapposition occurring after intracoronary beta-irradiation detected by intravascular ultrasound. J Invasive Cardiol 11:651-655
19. Mintz GS, Nissen SE, Anderson WD et al (2001) American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37:1478-1492
20. Costa MA, Sabate M, Angiolillo DJ et al (2006) Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation. Am J Cardiol 97:203-206
21. Costa MA, Sabate M, Angiolillo DJ et al (2007) Relocation of minimal lumen diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late loss. Catheter Cardiovasc Interv 69: 181-188
22. Kastrati A, Mehilli J, von Beckerath N et al (2005) Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 293:165-171
23. Sabate M, Costa MA, Kozuma K et al (2000) Methodological and clinical implications of the relocation of the minimal luminal diameter after intracoronary radiation therapy. Dose finding study group. J Am Coll Cardiol 36:1536-1541
24. Kastrati A, Elezi S, Dirschinger J et al (1999) Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 83:1617-1622
25. Kastrati A, Schomig A, Elezi S et al (1997) Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30:1428-1436
26. Haude M, Erbel R, Straub U et al (1991) Short and long term results after intracoronary stenting in human coronary arteries: Monocentre experience with the balloon-expandable Palmaz-Schatz stent. Br Heart J 66:337-345
27. Colombo A, Orlic D, Stankovic G et al (2003) Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 107:2178-2180
28. Serruys PW, Degertekin M, Tanabe K et al (2002) Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (Randomized study with the sirolimus-eluting velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions) trial. Circulation 106:798-803
29. Munoz JS, Abizaid A, Mintz GS et al (2004) Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents. Am J Cardiol 93:470-473
30. Kereiakes DJ, Wang H, Popma JJ et al (2006) Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: Pooled analysis of five clinical trials. J Am Coll Cardiol 48:21-31
31. Bouma BE, Tearney GJ, Yabushita H et al (2003) Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 89:317-320